Andrea Ferrigno

Dr. Andrea Ferrigno

Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
Mariapia VairettiMariapia Vairetti
Mariapia Vairetti
Laura Giuseppina Di PasquaLaura Giuseppina Di Pasqua
Laura Giuseppina Di Pasqua
MCMarta Cagna
Marta Cagna
PRPlinio Richelmi
Plinio Richelmi
AFAndrea Ferrigno
Andrea Ferrigno
CBClarissa Berardo
Clarissa Berardo
Glutathione (GSH), a tripeptide particularly concentrated in the liver, is the most important thiol reducing agent involved in the modulation of redox processes. It has also been demonstrated that GSH cannot be considered only as a mere free radical scavenger but that it takes part in the network governing the choice between survival, necrosis and apoptosis as well as in altering the function of signal transduction and transcription factor molecules. The purpose of the present review is to provide an overview on the molecular biology of the GSH system; therefore, GSH synthesis, metabolism and regulation will be reviewed. The multiple GSH functions will be described, as well as the importance of GSH compartmentalization into distinct subcellular pools and inter-organ transfer. Furthermore, we will highlight the close relationship existing between GSH content and the pathogenesis of liver disease, such as non-alcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD), chronic cholestatic injury, ischemia/reperfusion damage, hepatitis C virus (HCV), hepatitis B virus (HBV) and hepatocellular carcinoma. Finally, the potential therapeutic benefits of GSH and GSH-related medications, will be described for each liver disorder taken into account.

24 December 2008 in Liver Transplantation
Verified
Journal Article
Open access
PDF file
Mariapia VairettiMariapia Vairetti
Mariapia Vairetti
AFAndrea Ferrigno
Andrea Ferrigno
FCFilippo Carlucci
Filippo Carlucci
ATAntonella Tabucchi
Antonella Tabucchi
VRVittoria Rizzo
Vittoria Rizzo
Umberto CilloUmberto Cillo
Umberto Cillo
: We tested whether rat liver preservation performed by machine perfusion (MP) at 20°C can enhance the functional integrity of steatotic livers versus simple cold storage. We also compared MP at 20°C with hypothermic MP at 8°C, and 4°C. Obese and lean male Zucker rats were used as liver donors. MP was performed for 6 hours with a glucose and N-acetylcysteine–supplemented Krebs-Henseleit solution. Both MP and cold storage preserved livers were reperfused with Krebs-Henseleit solution (2 hours at 37°C). MP at 4°C and 8°C reduced the fatty liver necrosis compared with cold storage but we further protected the organs using MP at 20°C. Necrosis did not differ in livers from lean animals submitted to the different procedures; the enzymes released in steatotic livers preserved by MP at 20°C were similar to those showed in nonsteatotic organs. The adenosine triphosphate/adenosine diphosphate ratio and bile production were higher and the oxidative stress and biliary enzymes were lower in steatotic livers preserved by MP at 20°C as compared with cold storage. In livers from lean rats, the adenosine triphosphate/adenosine diphosphate ratio appears better conserved by MP at 20°C as compared with cold storage. In steatotic livers preserved by cold storage, a 2-fold increase in tumor necrosis factor-alpha levels and caspase-3 activity was observed as compared with organs preserved by MP at 20°C. These data are substantiated by better morphology, higher glycogen content, and lower reactive oxygen species production by sinusoidal cells in steatotic liver submitted to MP at 20°C versus cold storage. MP at 20°C improves cell survival and leads to a marked improvement in hepatic preservation of steatotic livers as compared with cold storage. Liver Transpl 15:20–29, 2009. © 2008 AASLD.

Verified
Journal Article
Open access
PDF file
CBClarissa Berardo
Clarissa Berardo
Laura Giuseppina Di PasquaLaura Giuseppina Di Pasqua
Laura Giuseppina Di Pasqua
MCMarta Cagna
Marta Cagna
PRPlinio Richelmi
Plinio Richelmi
Mariapia VairettiMariapia Vairetti
Mariapia Vairetti
AFAndrea Ferrigno
Andrea Ferrigno
Nonalcoholic fatty liver disease (NAFLD) is a continuum of liver abnormalities often starting as simple steatosis and to potentially progress into nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma. Because of its increasing prevalence, NAFLD is becoming a major public health concern, in parallel with a worldwide increase in the recurrence rate of diabetes and metabolic syndrome. It has been estimated that NASH cirrhosis may surpass viral hepatitis C and become the leading indication for liver transplantation in the next decades. The broadening of the knowledge about NASH pathogenesis and progression is of pivotal importance for the discovery of new targeted and more effective therapies; aim of this review is to offer a comprehensive and updated overview on NAFLD and NASH pathogenesis, the most recommended treatments, drugs under development and new drug targets. The most relevant in vitro and in vivo models of NAFLD and NASH will be also reviewed, as well as the main molecular pathways involved in NAFLD and NASH development.

6 April 2018 in Liver International
Verified
Journal Article
Open access
PDF file
Anna Cleta CroceAnna Cleta Croce
Anna Cleta Croce
AFAndrea Ferrigno
Andrea Ferrigno
GBGiovanni Bottiroli
Giovanni Bottiroli
MVMariapia Vairetti
Mariapia Vairetti
Autofluorescence emission of liver tissue depends on the presence of endogenous biomolecules able to fluoresce under suitable light excitation. Overall autofluorescence emission contains much information of diagnostic value because it is the sum of individual autofluorescence contributions from fluorophores involved in metabolism, for example, NAD(P)H, flavins, lipofuscins, retinoids, porphyrins, bilirubin and lipids, or in structural architecture, for example, fibrous proteins, in close relationship with normal, altered or diseased conditions of the liver. Since the 1950s, hepatocytes and liver have been historical models to study NAD(P)H and flavins as in situ, real‐time autofluorescence biomarkers of energy metabolism and redox state. Later investigations designed to monitor organ responses to ischaemia/reperfusion were able to predict the risk of dysfunction in surgery and transplantation or support the development of procedures to ameliorate the liver outcome. Subsequently, fluorescent fatty acids, lipofuscin‐like lipopigments and collagen were characterized as optical biomarkers of liver steatosis, oxidative stress damage, fibrosis and disease progression. Currently, serum AF is being investigated to improve non‐invasive optical diagnosis of liver disease. Validation of endogenous fluorophores and in situ discrimination of cancerous from non‐cancerous tissue belong to the few studies on liver in human subjects. These reports along with other optical techniques and the huge work performed on animal models suggest many optically based applications in hepatology. Optical diagnosis is currently offering beneficial outcomes in clinical fields ranging from the respiratory and gastrointestinal tracts, to dermatology and ophthalmology. Accordingly, this review aims to promote an effective bench to bedside transfer in hepatology.

31 August 2004 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
Anna Cleta CroceAnna Cleta Croce
Anna Cleta Croce
AFAndrea Ferrigno
Andrea Ferrigno
Mariapia VairettiMariapia Vairetti
Mariapia Vairetti
RBRoberta Bertone
Roberta Bertone
IFIsabel Freitas
Isabel Freitas
GBGiovanni Bottiroli
Giovanni Bottiroli
The contribution of endogenous fluorophores – such as proteins, bound and free NAD(P)H, flavins, vitamin A, arachidonic acid – to the liver autofluorescence was studied on tissue homogenate extracts and on isolated hepatocytes by means of spectrofluorometric analysis. Autofluorescence spectral analysis was then applied to investigate the response of single living hepatocytes to experimental conditions resembling the various phases of the organ transplantation. The following conditions were considered: 1 h after cells isolation (reference condition); cold hypoxia; rewarming–reoxygenation after cold preservation. The main alterations occurred for NAD(P)H and flavins, the coenzymes strictly involved in energetic metabolism. During cold hypoxia NAD(P)H, mainly the bound form, showed an increase followed by a slow decrease, in agreement with the inability of the respiratory chain to reoxidize the coenzyme, and a subsequent NADH reoxidation through alternative anaerobic metabolic pathways. Both bound/free NAD(P)H and total NAD(P)H/flavin ratio values were altered during cold hypoxia, but approached the reference condition values after rewarming–reoxygenation, indicating the cells capability to restore the basal redox equilibrium. A decrease of arachidonic acid and vitamin A contributions occurred after cold hypoxia: in the former case it may depend on the balance between deacylation and reacylation of fatty acids, in the latter it might be related to the vitamin A antioxidant role. An influence of physico-chemical status and microenvironment on the fluorescence efficiency of these fluorophores cannot be excluded. In general, all the changes observed for cell autofluorescence properties were consistent with the complex metabolic pathways providing for energy supply.

19 November 2004 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
Mariapia VairettiMariapia Vairetti
Mariapia Vairetti
AFAndrea Ferrigno
Andrea Ferrigno
RBRoberta Bertone
Roberta Bertone
VRVittoria Rizzo
Vittoria Rizzo
PRPlinio Richelmi
Plinio Richelmi
IFIsabel Freitas
Isabel Freitas